GE HealthCare Announces FES PET Imaging Recommendation in NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)
Imaging Technology
MAY 25, 2023
GE HealthCare’s Cerianna , available in the U.S., Detecting ER+ lesions in patients with recurrent or metastatic breast cancer could potentially aid oncologists, surgeons and clinicians in choosing the most appropriate therapy for patients.” cancer centers devoted to patient care, research, and education.
Let's personalize your content